Evidence map›Paper›PMID 37991527›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

Granzyme B PET imaging inflammation and remodeling in myocardial infarction.

Hongchuang Xu, Zhuxin Wei, Bixi Chen, Jiaxin Wang, Haoyu Weng, Jianping Li, Xing Yang, Shihua Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. The molecular symphony of myocardial repair: RGD, FAPI, and granzyme B PET in concert.European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hongchuang XuDepartment of Nuclear Medicine, Peking University First Hospital, Xishiku Rd 8, Xicheng District, Beijing, 100034, China.
Zhuxin WeiDepartment of MRI, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beilishi Rd 167, Xicheng District, Beijing, 100037, China.
Bixi ChenDepartment of Nuclear Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Jiaxin WangDepartment of MRI, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beilishi Rd 167, Xicheng District, Beijing, 100037, China.
Haoyu WengDepartment of Cardiology, Peking University First Hospital, Xishiku Rd 8, Xicheng District, Beijing, 100034, China.
Jianping LiDepartment of Cardiology, Peking University First Hospital, Xishiku Rd 8, Xicheng District, Beijing, 100034, China. lijianping03455@pkufh.com.
Xing YangDepartment of Nuclear Medicine, Peking University First Hospital, Xishiku Rd 8, Xicheng District, Beijing, 100034, China. yangxing2017@bjmu.edu.cn.
Shihua ZhaoDepartment of MRI, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beilishi Rd 167, Xicheng District, Beijing, 100037, China. cjrzhaoshihua2009@163.com.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University First Hospital · CNCapital Medical University · CNPeking University · CN

Funding

National Key Research and Development Program of China 2021YFF0501400National Key Research and Development Program of China 2021YFF0501404National Natural Science Foundation of China 22277002National Natural Science Foundation of China 92059101
6 · The paper itself

Abstract

purposeThis study aimed to evaluate whether granzyme B (GzmB)-targeted positron emission tomography (PET) imaging agent (

methodsRats with MI were subjected to GzmB-targeted PET/CT on post-operative days 1, 3, 6, 14, and 28. Autoradiography, Masson staining, immunohistochemistry, and ELISA were performed to verify the inflammatory response and remodeling after MI in vitro. Rats were treated with GzmB inhibitor Z-IETD-FMK to improve cardiac remodeling. Cardiac function tests were performed by echocardiography at 6 weeks after MI.

resultsThe highest uptake of

conclusionsThis study demonstrated the potential of

Indexed as

Myocardial InfarctionPositron Emission Tomography Computed TomographyAnimalsGranzymesInflammationMyocardiumPositron-Emission TomographyRatsStroke VolumeVentricular Function, LeftVentricular RemodelingGranzymesCardiac functionGranzyme BInflammatoryMyocardial infarctionPET/CT imagingVentricular remodeling

Identifiers

PMID37991527
OpenAlexW4388905511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.